|
US5885567A
(en)
*
|
1993-10-22 |
1999-03-23 |
University Of Connecticut |
Treatment of infection in fowl by oral administration of avian interferon proteins
|
|
GB9700624D0
(en)
|
1997-01-14 |
1997-03-05 |
Danbiosyst Uk |
Drug delivery composition
|
|
WO1999001579A1
(en)
|
1997-07-01 |
1999-01-14 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for the delivery of oligonucleotides via the alimentary canal
|
|
US8765177B2
(en)
*
|
1997-09-12 |
2014-07-01 |
Columbia Laboratories, Inc. |
Bioadhesive progressive hydration tablets
|
|
US7153845B2
(en)
*
|
1998-08-25 |
2006-12-26 |
Columbia Laboratories, Inc. |
Bioadhesive progressive hydration tablets
|
|
US6423334B1
(en)
|
1997-10-01 |
2002-07-23 |
Elan Corporation, Plc |
Composition and method for enhancing transport across gastrointestinal tract cell layers
|
|
SE9703691D0
(sv)
*
|
1997-10-10 |
1997-10-10 |
Astra Ab |
Pharmaceutical compositions
|
|
FR2775188B1
(fr)
*
|
1998-02-23 |
2001-03-09 |
Lipha |
Forme galenique a liberation immediate ou liberation prolongee administrable par voie orale comprenant un agent promoteur d'absorption et utilisation de cet agent promoteur d'absorption
|
|
US6099859A
(en)
*
|
1998-03-20 |
2000-08-08 |
Andrx Pharmaceuticals, Inc. |
Controlled release oral tablet having a unitary core
|
|
CA2329130A1
(en)
*
|
1998-05-21 |
1999-11-25 |
Isis Pharmaceuticals Inc. |
Compositions and methods for non-parenteral delivery of oligonucleotides
|
|
GB9824604D0
(en)
*
|
1998-11-11 |
1999-01-06 |
Hewlett Healthcare Limited |
Treatment of allergic conditions
|
|
JP2002531518A
(ja)
*
|
1998-12-04 |
2002-09-24 |
プロヴァリス・ユーケー・リミテッド |
インスリン含有医薬組成物
|
|
DE60038097T2
(de)
*
|
1999-02-22 |
2009-02-12 |
Merrion Research I Ltd. |
Feste orale dosierungsform enthaltend einen resorptionsverstärker
|
|
US8119159B2
(en)
*
|
1999-02-22 |
2012-02-21 |
Merrion Research Iii Limited |
Solid oral dosage form containing an enhancer
|
|
US20070148228A1
(en)
*
|
1999-02-22 |
2007-06-28 |
Merrion Research I Limited |
Solid oral dosage form containing an enhancer
|
|
US7658938B2
(en)
|
1999-02-22 |
2010-02-09 |
Merrion Reasearch III Limited |
Solid oral dosage form containing an enhancer
|
|
SE9901272D0
(sv)
*
|
1999-04-09 |
1999-04-09 |
Astra Ab |
New improved formulation
|
|
US7169889B1
(en)
*
|
1999-06-19 |
2007-01-30 |
Biocon Limited |
Insulin prodrugs hydrolyzable in vivo to yield peglylated insulin
|
|
YU43702A
(sh)
|
1999-12-23 |
2004-11-25 |
Pfizer Products Inc. |
Farmaceutske kompozicije koje obezbeđuju povećanje koncentracije leka
|
|
US6726932B2
(en)
|
2000-02-18 |
2004-04-27 |
Nippon Zoki Pharmaceutical Co., Ltd. |
Fatty acid-containing composition
|
|
JP2001240558A
(ja)
*
|
2000-02-29 |
2001-09-04 |
Nippon Suisan Kaisha Ltd |
多価不飽和脂肪酸を経粘膜吸収促進剤として含有する固形製剤。
|
|
EP1346726A4
(de)
*
|
2000-12-25 |
2004-09-15 |
Shiseido Co Ltd |
Parfumzusammenstellung die das sympathetische system stimulieren
|
|
US7060675B2
(en)
*
|
2001-02-15 |
2006-06-13 |
Nobex Corporation |
Methods of treating diabetes mellitus
|
|
US6867183B2
(en)
*
|
2001-02-15 |
2005-03-15 |
Nobex Corporation |
Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
|
|
JP2004525110A
(ja)
*
|
2001-02-16 |
2004-08-19 |
清水製薬株式会社 |
ムコ多糖類製剤およびその製造法
|
|
DK1900364T3
(da)
*
|
2001-04-18 |
2014-01-13 |
Prometic Biosciences Inc |
Fedtsyrer, glycerider og analoger med medium kædelængde som neutrofile overlevelses- og aktiveringsfaktorer
|
|
ATE547095T1
(de)
|
2001-05-11 |
2012-03-15 |
Isis Pharmaceuticals Inc |
Antisense-permeationsverstärker
|
|
EP1390024A4
(de)
*
|
2001-05-11 |
2010-02-17 |
Merrion Res Iii Ltd |
Isostearinsäuresalze als permeationsverbesserer
|
|
US6713452B2
(en)
|
2001-06-04 |
2004-03-30 |
Nobex Corporation |
Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
|
US6858580B2
(en)
|
2001-06-04 |
2005-02-22 |
Nobex Corporation |
Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
|
US6828305B2
(en)
*
|
2001-06-04 |
2004-12-07 |
Nobex Corporation |
Mixtures of growth hormone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
|
US6835802B2
(en)
|
2001-06-04 |
2004-12-28 |
Nobex Corporation |
Methods of synthesizing substantially monodispersed mixtures of polymers having polyethylene glycol moieties
|
|
US7713932B2
(en)
*
|
2001-06-04 |
2010-05-11 |
Biocon Limited |
Calcitonin drug-oligomer conjugates, and uses thereof
|
|
US6828297B2
(en)
*
|
2001-06-04 |
2004-12-07 |
Nobex Corporation |
Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
|
JP4381805B2
(ja)
*
|
2001-07-02 |
2009-12-09 |
メリオン リサーチ スリー リミテッド |
生物活性材料の送達
|
|
IL159578A0
(en)
*
|
2001-07-06 |
2004-06-01 |
Geron Corp |
Messenchymal cells and osteoblasts from human embryonic stem cell
|
|
US6913903B2
(en)
*
|
2001-09-07 |
2005-07-05 |
Nobex Corporation |
Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
|
|
US7030082B2
(en)
*
|
2001-09-07 |
2006-04-18 |
Nobex Corporation |
Pharmaceutical compositions of drug-oligomer conjugates and methods of treating disease therewith
|
|
US7166571B2
(en)
*
|
2001-09-07 |
2007-01-23 |
Biocon Limited |
Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
|
|
US6770625B2
(en)
|
2001-09-07 |
2004-08-03 |
Nobex Corporation |
Pharmaceutical compositions of calcitonin drug-oligomer conjugates and methods of treating diseases therewith
|
|
US7312192B2
(en)
*
|
2001-09-07 |
2007-12-25 |
Biocon Limited |
Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
|
|
US7196059B2
(en)
*
|
2001-09-07 |
2007-03-27 |
Biocon Limited |
Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
|
|
SI1456380T1
(sl)
*
|
2001-11-02 |
2012-11-30 |
Giuliani Int Ltd |
Smad inhibitorji za zdravljenje cns bolezni
|
|
MY139721A
(en)
*
|
2002-04-19 |
2009-10-30 |
Cpex Pharmaceuticals Inc |
Pharmaceutical composition
|
|
GB0210397D0
(en)
*
|
2002-05-07 |
2002-06-12 |
Ferring Bv |
Pharmaceutical formulations
|
|
WO2003105768A2
(en)
|
2002-06-13 |
2003-12-24 |
Nobex Corporation |
Methods of reducing hypoglycemic episodes in the treatment of diabetes mellitus
|
|
AU2003302888A1
(en)
*
|
2002-12-11 |
2004-06-30 |
Chong Kun Dang Pharmaceutical Corp. |
Oral formulations for poorly absorptive hydrophilic drugs
|
|
BRPI0407276A
(pt)
|
2003-02-07 |
2006-01-31 |
Prometic Biosciences Inc |
ácidos graxos, glicerìdeos e análogos com comprimento de cadeia médio, como estimulantes de eritropoiese
|
|
ITRM20030149A1
(it)
|
2003-04-02 |
2004-10-03 |
Giuliani Spa |
Oligonucleotidi (odn) antisenso per smad7 e loro usi in campo medico
|
|
KR101152470B1
(ko)
|
2003-08-13 |
2012-06-01 |
바이오콘 리미티드 |
치료제용 마이크로-입자 지방산 염 고형 투약 제형
|
|
RU2006118801A
(ru)
*
|
2003-10-31 |
2007-12-10 |
Алза Корпорейшн (Us) |
Композиции и лекарственные формы для усиления всасывания габапентина и прегабалина
|
|
EP1728504B1
(de)
*
|
2004-03-24 |
2013-07-31 |
Takeda Pharmaceutical Company Limited |
Emulsionsstabilisator
|
|
CA2563533C
(en)
*
|
2004-04-15 |
2013-10-01 |
Shmuel A. Ben-Sasson |
Compositions capable of facilitating penetration across a biological barrier
|
|
US20070219131A1
(en)
*
|
2004-04-15 |
2007-09-20 |
Ben-Sasson Shmuel A |
Compositions capable of facilitating penetration across a biological barrier
|
|
US20080286359A1
(en)
*
|
2004-05-24 |
2008-11-20 |
Richard John Dansereau |
Low Dosage Forms Of Risedronate Or Its Salts
|
|
US7645460B2
(en)
*
|
2004-05-24 |
2010-01-12 |
The Procter & Gamble Company |
Dosage forms of risedronate
|
|
US7645459B2
(en)
|
2004-05-24 |
2010-01-12 |
The Procter & Gamble Company |
Dosage forms of bisphosphonates
|
|
US20080287400A1
(en)
*
|
2004-05-24 |
2008-11-20 |
Richard John Dansereau |
Low Dosage Forms Of Risedronate Or Its Salts
|
|
CN101027318B
(zh)
*
|
2004-07-19 |
2016-05-25 |
比奥孔有限公司 |
胰岛素-低聚物共轭物,制剂及其用途
|
|
CA2578404A1
(en)
*
|
2004-08-23 |
2006-03-02 |
Auckland Uniservices Limited |
Gastric therapies and compositions therefor
|
|
MY139644A
(en)
*
|
2005-02-17 |
2009-10-30 |
Palm Nutraceuticals Sdn Bhd |
Improving the quality of crude oils and fats and recovery of minor components
|
|
US20090149434A1
(en)
*
|
2005-09-29 |
2009-06-11 |
Joseph Podolski |
Formulations with improved bioavailability, comprising a steroid derivative and a polyglycolysed glyceride
|
|
JP5047978B2
(ja)
*
|
2005-10-13 |
2012-10-10 |
バイオコン・リミテッド |
インスリン複合体の調製のための方法
|
|
US8920918B2
(en)
*
|
2005-10-31 |
2014-12-30 |
Kee Action Sports Technology Holdings, Llc |
Oil and polyethylene glycol fill material for use in paintball shells
|
|
AU2007285472B2
(en)
*
|
2006-03-30 |
2013-10-24 |
Engene, Inc. |
Non-viral compositions and methods for transfecting gut cells in vivo
|
|
BRPI0710503A2
(pt)
*
|
2006-04-07 |
2011-08-16 |
Merrion Res Iii Ltd |
uso de uma composição farmacêutica, composição farmacêutica, e, forma de dosagem oral
|
|
WO2007146234A2
(en)
*
|
2006-06-09 |
2007-12-21 |
Merrion Research Ii Limited |
Solid oral dosage form containing an enhancer
|
|
US9241908B2
(en)
*
|
2007-10-16 |
2016-01-26 |
Biocon Limited |
Orally administrable solid pharmaceutical composition and a process thereof
|
|
US20090271021A1
(en)
*
|
2008-04-28 |
2009-10-29 |
Popp Shane M |
Execution system for the monitoring and execution of insulin manufacture
|
|
US20090280169A1
(en)
*
|
2008-05-07 |
2009-11-12 |
Merrion Research Iii Limited |
Compositions of peptides and processes of preparation thereof
|
|
GB0808537D0
(en)
*
|
2008-05-12 |
2008-06-18 |
Archimedes Dev Ltd |
Compositions
|
|
RU2678833C2
(ru)
*
|
2008-09-17 |
2019-02-04 |
Киазма Инк. |
Фармацевтические композиции и соответствующие способы доставки
|
|
US20100064927A1
(en)
*
|
2008-09-17 |
2010-03-18 |
Aldo Perrone |
Starch-based paintball fill material
|
|
AU2015201581B2
(en)
*
|
2008-09-17 |
2017-03-09 |
Amryt Endo, Inc. |
Pharmaceutical Compositions and Related Methods of Delivery
|
|
TWI480286B
(zh)
*
|
2009-02-25 |
2015-04-11 |
Merrion Res Iii Ltd |
雙膦酸鹽類組合物及藥物遞送
|
|
CA2765221C
(en)
|
2009-06-18 |
2017-10-03 |
Allergan, Inc. |
Safe desmopressin administration
|
|
JP5711730B2
(ja)
|
2009-06-25 |
2015-05-07 |
コーニンクレッカ フィリップス エヌ ヴェ |
熱管理装置
|
|
US20160016982A1
(en)
|
2009-07-31 |
2016-01-21 |
Thar Pharmaceuticals, Inc. |
Crystallization method and bioavailability
|
|
US9169279B2
(en)
|
2009-07-31 |
2015-10-27 |
Thar Pharmaceuticals, Inc. |
Crystallization method and bioavailability
|
|
KR101813728B1
(ko)
|
2009-07-31 |
2017-12-29 |
그뤼넨탈 게엠베하 |
결정화 방법 및 생체이용률
|
|
EP2512454A2
(de)
|
2009-12-16 |
2012-10-24 |
Nod Pharmaceuticals, Inc. |
Zusammensetzungen und verfahren zur wirkstofffreisetzung
|
|
US20110142889A1
(en)
*
|
2009-12-16 |
2011-06-16 |
Nod Pharmaceuticals, Inc. |
Compositions and methods for oral drug delivery
|
|
BR112012016853A2
(pt)
*
|
2010-01-12 |
2017-10-17 |
Novo Nordisk As |
"composições farmacêuticas para administração oral de peptídeos de insulina".
|
|
US20110182985A1
(en)
*
|
2010-01-28 |
2011-07-28 |
Coughlan David C |
Solid Pharmaceutical Composition with Enhancers and Methods of Preparing thereof
|
|
US9089484B2
(en)
|
2010-03-26 |
2015-07-28 |
Merrion Research Iii Limited |
Pharmaceutical compositions of selective factor Xa inhibitors for oral administration
|
|
WO2012071517A2
(en)
|
2010-11-24 |
2012-05-31 |
Thar Pharmaceuticals, Inc. |
Novel crystalline forms
|
|
EP2661273A4
(de)
|
2011-01-07 |
2014-06-04 |
Merrion Res Iii Ltd |
Pharmazeutische zusammensetzungen aus eisen zur oralen verabreichung
|
|
JP7211704B2
(ja)
|
2015-01-29 |
2023-01-24 |
ノヴォ ノルディスク アー/エス |
Glp-1アゴニスト及び腸溶コーティングを含む錠剤
|
|
SI3253401T1
(sl)
|
2015-02-03 |
2025-07-31 |
Amryt Endo, Inc. |
Zdravljenje akromegalije z oralnim oktreotidom
|
|
GB201511284D0
(en)
*
|
2015-06-26 |
2015-08-12 |
Univ Witwatersrand Jhb |
An oral pharmaceutical dosage form for the delivery of a peptide and/or protein
|
|
WO2017208070A1
(en)
|
2016-05-31 |
2017-12-07 |
Grünenthal GmbH |
Bisphosphonic acid and coformers with lysin, glycin, nicotinamide for treating psoriatic arthritis
|
|
GB201904771D0
(en)
|
2019-04-04 |
2019-05-22 |
Orexo Ab |
New pharmaceutical compositions
|
|
GB201904767D0
(en)
|
2019-04-04 |
2019-05-22 |
Orexo Ab |
New pharmaceutical compositions
|
|
US11141457B1
(en)
|
2020-12-28 |
2021-10-12 |
Amryt Endo, Inc. |
Oral octreotide therapy and contraceptive methods
|
|
US11896719B2
(en)
|
2022-01-24 |
2024-02-13 |
Calliditas Therapeutics Ab |
Pharmaceutical compositions
|